Tuesday, July 22, 2008
Isotechnika says Roche gives up global rights to voclosporin for organ transplants
EDMONTON - Canadian drug developer Isotechnika Inc. says Swiss drug giant Roche has given up its rights to license the Edmonton company's voclosporin drug for solid organ transplants....More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment